RAPT Therapeutics Inc (RAPT)
4.03
-0.11
(-2.66%)
USD |
NASDAQ |
May 17, 16:00
4.03
0.00 (0.00%)
After-Hours: 20:00
RAPT Therapeutics Free Cash Flow: -106.00M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | -106.00M |
December 31, 2023 | -98.17M |
September 30, 2023 | -93.25M |
June 30, 2023 | -88.53M |
March 31, 2023 | -75.25M |
December 31, 2022 | -71.62M |
September 30, 2022 | -69.79M |
June 30, 2022 | -65.15M |
March 31, 2022 | -63.37M |
December 31, 2021 | -61.78M |
September 30, 2021 | -56.25M |
Date | Value |
---|---|
June 30, 2021 | -53.74M |
March 31, 2021 | -46.18M |
December 31, 2020 | -40.89M |
September 30, 2020 | -31.06M |
June 30, 2020 | -33.20M |
March 31, 2020 | -36.15M |
December 31, 2019 | -36.36M |
September 30, 2019 | -41.51M |
June 30, 2019 | -38.96M |
March 31, 2019 | -37.45M |
December 31, 2018 | -36.45M |
Free Cash Flow Range, Past 5 Years
-106.00M
Minimum
Mar 2024
-31.06M
Maximum
Sep 2020
-60.36M
Average
-59.01M
Median
Free Cash Flow Benchmarks
Emergent BioSolutions Inc | -132.20M |
Avinger Inc | -14.44M |
Tonix Pharmaceuticals Holding Corp | -90.87M |
Skye Bioscience Inc | -14.61M |
Axsome Therapeutics Inc | -193.34M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -27.08M |
Cash from Investing (Quarterly) | 15.89M |
Cash from Financing (Quarterly) | 9.036M |
Free Cash Flow Per Share (Quarterly) | -0.7039 |
Free Cash Flow Yield | -68.28% |